Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel: Endo opioid painkiller's risks outweigh its benefits
FDA panel: Endo opioid painkiller's risks outweigh its benefits
FDA panel: Endo opioid painkiller's risks outweigh its benefits
Submitted by
admin
on March 15, 2017 - 11:23am
Source:
Bizjournals.com
News Tags:
FDA
advisory panels
Endo International
Opana ER
opioids
painkillers
Headline:
FDA panel: Endo opioid painkiller's risks outweigh its benefits
Do Not Allow Advertisers to Use My Personal information
